Alteration of plasma interleukin-18 level in leukemia patients and its clinical significance / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 542-543, 2003.
Article
em Zh
| WPRIM
| ID: wpr-278843
Biblioteca responsável:
WPRO
ABSTRACT
To explore the alteration of plasma level of IL-18 in patients with leukemia before and after chemotherapy and its clinical significance, the plasma level of IL-18 was determined with ELISA method before and 2 weeks after chemotherapy in 37 leukemia patients, and 18 normal individuals. The results showed that the plasma IL-18 level (153.34 +/- 50.74 pg/ml) in leukemia patients was similar to the level (135.82 +/- 47.00 pg/ml) in normal control, and the IL-18 level in ALL patients was significantly increased (173.3 +/- 34.4 pg/ml), while the IL-18 level in CML patients (111.8 +/- 50.5 pg/ml) was lower than normal level. After chemotherapy, the IL-18 level (100.89 +/- 50.07 pg/ml) was significantly lower than normal level and oneself before treatment. It is concluded that plasma IL-18 levels in leukemia patients are un-homogeneous and IL-18 production decreased after chemotherapy, and immunologic hypofunction in patients with chemotherapy might be related with the decrease of IL-18 and related cytokines.
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Sangue
/
Ensaio de Imunoadsorção Enzimática
/
Leucemia
/
Interferon gama
/
Interleucina-18
/
Tratamento Farmacológico
Limite:
Adolescent
/
Adult
/
Aged
/
Child
/
Female
/
Humans
/
Male
Idioma:
Zh
Revista:
Journal of Experimental Hematology
Ano de publicação:
2003
Tipo de documento:
Article